New quinoxaline derivatives as potential MT₁ and MT₂ receptor ligands.
Ever since the idea arose that melatonin might promote sleep and resynchronize circadian rhythms, many research groups have centered their efforts on obtaining new melatonin receptor ligands whose pharmacophores include an aliphatic chain of variable length united to an N-alkylamide and a methoxy...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | info:eu-repo/semantics/article |
| Language: | eng |
| Published: |
MDPI
2012
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10171/23603 |